Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Autoimmune Disorders

  Free Subscription


1 Acta Neurol Scand
2 Am J Kidney Dis
1 BMC Neurol
1 Diabet Med
2 Diabetes Res Clin Pract
2 Intern Med
3 J Immunol
1 J Neuroimmunol
4 J Neurol
4 Kidney Int
1 Lancet
2 Mult Scler
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neurol Scand

  1. DONSKOV AO, Vinge L, Axelsen SM, Andersen H, et al
    Overactive bladder in patients with myasthenia gravis-A cross-sectional population-based study.
    Acta Neurol Scand. 2021 Mar 27. doi: 10.1111/ane.13419.
    PubMed         Abstract available

    Am J Kidney Dis

  2. INKER LA, Lambers-Heerspink H, Tighiouart H, Chaudhari J, et al
    Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
    Am J Kidney Dis. 2021 Mar 25. pii: S0272-6386(21)00502.
    PubMed         Abstract available

  3. STEINBERG AG, Fox LC, Bender S, Batrouney A, et al
    Proliferative Glomerulonephritis With Fibrils, Monoclonal kappa Light Chain, and C3 Deposits.
    Am J Kidney Dis. 2021 Mar 24. pii: S0272-6386(21)00499.
    PubMed         Abstract available

    BMC Neurol

  4. BONG JB, Lee DK, Lee MA, Hwang BW, et al
    Immunoglobulin G4-related disease presenting with peripheral neuropathy: a case report.
    BMC Neurol. 2021;21:41.
    PubMed         Abstract available

    Diabet Med

  5. HAWKES CP, Willi SM
    A trend towards early increases in ketoacidosis at presentation of pediatric type 1 diabetes during the coronavirus-2019 pandemic.
    Diabet Med. 2020 Nov 25:e14461. doi: 10.1111/dme.14461.
    PubMed         Abstract available

    Diabetes Res Clin Pract

  6. STROLLO F, Furia A, Verde P, Bellia A, et al
    Technological innovation of Continuous Glucose Monitoring (CGM) as a tool for commercial aviation pilots with insulin-treated diabetes and stakeholders/regulators: A new chance to improve the directives?
    Diabetes Res Clin Pract. 2021;172:108638.
    PubMed         Abstract available

  7. ZURAWSKA-KLIS M, Kosinski M, Kuchnicka A, Rurka M, et al
    Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
    Diabetes Res Clin Pract. 2021;172:108628.
    PubMed         Abstract available

    Intern Med

  8. YAMAGUCHI Y, Aso M, Nagasawa H, Wada M, et al
    Atezolizumab-associated Dermatomyositis in Advanced Lung Small-cell Carcinoma.
    Intern Med. 2021 Mar 29. doi: 10.2169/internalmedicine.6917.
    PubMed         Abstract available

  9. WATANABE A, Shiseki M, Oishi M, Kobayashi M, et al
    Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports.
    Intern Med. 2021 Mar 29. doi: 10.2169/internalmedicine.6387.
    PubMed         Abstract available

    J Immunol

  10. RACINE JJ, Chapman HD, Doty R, Cairns BM, et al
    T Cells from NOD-PerIg Mice Target Both Pancreatic and Neuronal Tissue.
    J Immunol. 2020;205:2026-2038.
    PubMed         Abstract available

  11. YE C, Low BE, Wiles MV, Brusko TM, et al
    CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.
    J Immunol. 2020 Aug 31. pii: jimmunol.2000148. doi: 10.4049/jimmunol.2000148.
    PubMed         Abstract available

  12. CHO T, Sato H, Wakamatsu A, Ohashi R, et al
    Mood Disorder in Systemic Lupus Erythematosus Induced by Antiribosomal P Protein Antibodies Associated with Decreased Serum and Brain Tryptophan.
    J Immunol. 2021 Mar 31. pii: jimmunol.2000260. doi: 10.4049/jimmunol.2000260.
    PubMed         Abstract available

    J Neuroimmunol

  13. GUEDES BF, Ribeiro AF, Pinto LF, Vidal JE, et al
    Potential autoimmune encephalitis following yellow fever vaccination: A report of three cases.
    J Neuroimmunol. 2021;355:577548.
    PubMed         Abstract available

    J Neurol

  14. ZEIDAN S, Maillart E, Louapre C, Roux T, et al
    COVID-19 infection in NMO/SD patients: a French survey.
    J Neurol. 2021;268:1188-1190.

  15. MATHEY G, Pische G, Soudant M, Pittion-Vouyovitch S, et al
    Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.
    J Neurol. 2021 Mar 31. pii: 10.1007/s00415-021-10501.
    PubMed         Abstract available

  16. PINTER D, Kober SE, Fruhwirth V, Berger L, et al
    MRI correlates of cognitive improvement after home-based EEG neurofeedback training in patients with multiple sclerosis: a pilot study.
    J Neurol. 2021 Mar 30. pii: 10.1007/s00415-021-10530.
    PubMed         Abstract available

  17. OZAWA Y, Uzawa A, Yasuda M, Kojima Y, et al
    Long-term outcomes and prognostic factors in generalized myasthenia gravis.
    J Neurol. 2021 Mar 27. pii: 10.1007/s00415-021-10520.
    PubMed         Abstract available

    Kidney Int

  18. NEGREA L, Rovin BH
    Gross Hematuria Following Vaccination for SARS-CoV2 in Two Patients with IgA Nephropathy.
    Kidney Int. 2021 Mar 23. pii: S0085-2538(21)00286.

    Complement in membranous nephropathy: what we thought we knew and what we really know.
    Kidney Int. 2021 Mar 24. pii: S0085-2538(21)00297.

  20. ARTINGER K, Kirsch AH, Mooslechner AA, Cooper DJ, et al
    Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis.
    Kidney Int. 2021 Mar 27. pii: S0085-2538(21)00345.
    PubMed         Abstract available

  21. FERNANDEZ-JUAREZ G, Rojas-Rivera J, Praga M
    The authors reply.
    Kidney Int. 2021;99:1024-1025.


  22. LLEO A, Wang GQ, Gershwin ME, Hirschfield GM, et al
    Primary biliary cholangitis.
    Lancet. 2020;396:1915-1926.
    PubMed         Abstract available

    Mult Scler

  23. HOWLETT-PRIETO Q, Feng X, Kramer JF, Kramer KJ, et al
    Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis.
    Mult Scler. 2021 Mar 30:13524585211003301. doi: 10.1177/13524585211003301.
    PubMed         Abstract available

  24. THEODORSDOTTIR A, Debrabant B, Magyari M, Kant M, et al
    Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry.
    Mult Scler. 2021 Mar 29:13524585211003291. doi: 10.1177/13524585211003291.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  25. MANOUCHEHRI N, Hussain RZ, Cravens PD, Esaulova E, et al
    CD11c(+)CD88(+)CD317(+) myeloid cells are critical mediators of persistent CNS autoimmunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.